Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander T Baker

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Viruses|August 28, 2021
In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic ApplicationsEmily A Bates, John R Counsell, Sophie Alizert, et al.
Molecular Therapy Oncolytics|March 27, 2023
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcomaChelsae R Watters, Oumar Barro, Natalie M Elliott, et al.
Plos Pathogens|April 28, 2026
Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10Rosie M Mundy, Kasim Waraich, Emily A Bates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Ad5<sub>NULL</sub>-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer TherapiesHanni Uusi-Kerttula, James A Davies, Jill M Thompson, et al.
Molecular Therapy Oncolytics|August 26, 2020
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic CancersBolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, et al.
NPJ Vaccines|November 9, 2022
Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccinationAlessandra Buoninfante, Arno Andeweg, Alexander T Baker, et al.
Molecular Therapy Oncolytics|April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10Emily A Bates, James A Davies, Jana Váňová, et al.
Molecular Therapy. Methods & Clinical Development|August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applicationsCarly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
Science Advances|December 1, 2021
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndromeAlexander T Baker, Ryan J Boyd, Daipayan Sarkar, et al.
Iscience|January 9, 2026
Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4Erwan Sallard, Daniel Pembaur, Matias Ciancaglini, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Viruses|August 28, 2021
In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic ApplicationsEmily A Bates, John R Counsell, Sophie Alizert, et al.
Molecular Therapy Oncolytics|March 27, 2023
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcomaChelsae R Watters, Oumar Barro, Natalie M Elliott, et al.
Plos Pathogens|April 28, 2026
Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10Rosie M Mundy, Kasim Waraich, Emily A Bates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Ad5<sub>NULL</sub>-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer TherapiesHanni Uusi-Kerttula, James A Davies, Jill M Thompson, et al.
Molecular Therapy Oncolytics|August 26, 2020
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic CancersBolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, et al.
NPJ Vaccines|November 9, 2022
Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccinationAlessandra Buoninfante, Arno Andeweg, Alexander T Baker, et al.
Molecular Therapy Oncolytics|April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10Emily A Bates, James A Davies, Jana Váňová, et al.
Molecular Therapy. Methods & Clinical Development|August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applicationsCarly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
Science Advances|December 1, 2021
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndromeAlexander T Baker, Ryan J Boyd, Daipayan Sarkar, et al.
Iscience|January 9, 2026
Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4Erwan Sallard, Daniel Pembaur, Matias Ciancaglini, et al.
Pageof 3